3.8 Review

Cardiovascular Diseases in the Digital Health Era: A Translational Approach from the Lab to the Clinic

期刊

BIOTECH
卷 11, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/biotech11030023

关键词

cardiovascular diseases; translational medicine; digital health

资金

  1. Instituto de Salud Carlos III [PI16/01123, DTS16/0160, PI17/01059, PI19/00161, PI20/01618, DTS21/00064, PI18/01895, Red TERCEL RETIC RD16/0011/0029, RICORS RD21/0017, 002]
  2. Regional Government of Madrid [S2017/BMD-3962]
  3. Spanish Ministry of Science and Innovation (CIBERCV)
  4. European Union [874827 (BRAV3)]

向作者/读者索取更多资源

Translational science plays a crucial role in connecting basic and clinical levels in the field of cardiovascular diseases, aiming to transfer potential treatments from preclinical stages to clinical practice. The introduction of digital health solutions has enhanced this transfer process.
Translational science has been introduced as the nexus among the scientific and the clinical field, which allows researchers to provide and demonstrate that the evidence-based research can connect the gaps present between basic and clinical levels. This type of research has played a major role in the field of cardiovascular diseases, where the main objective has been to identify and transfer potential treatments identified at preclinical stages into clinical practice. This transfer has been enhanced by the intromission of digital health solutions into both basic research and clinical scenarios. This review aimed to identify and summarize the most important translational advances in the last years in the cardiovascular field together with the potential challenges that still remain in basic research, clinical scenarios, and regulatory agencies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据